Exelixis
EXEL
#1458
Rank
NZ$26.42 B
Marketcap
NZ$106.66
Share price
1.42%
Change (1 day)
58.27%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company